Pfizer Halts Clinical Trials In Russia But Will Continue To Supply Medicine

An anonymous reader quotes a report from Time: Pfizer said it would no longer start new clinical trials in Russia and that it would donate all profits from its subsidiary in the country to Ukraine relief causes. At the same time, the drugmaker said in a statement that it will continue to supply medicines to Russia, out of fear that vulnerable patients such as children and elderly people who rely on its therapies could be harmed by any halt. The company "concluded that a voluntary pause in the flow of our medicines to Russia would be in direct violation of our foundational principle of putting patients first," according to the statement. Pfizer said it doesn't own or operate any manufacturing sites in Russia and plans to cease planned investments with local suppliers. Pfizer said it would work with the U.S. Food and Drug Administration and other regulators to move current clinical trials to alternative locations outside of Russia. Patients already enrolled in studies will continue to receive medications, the company said.

Read more of this story at Slashdot.